Flotillin-2 is associated with breast cancer progression and poor survival outcomes

Abstract

The current results demonstrated that high FLOT2 protein expression was associated with poor outcomes in patients with breast cancer. FLOT2 could be used as a prognostic biomarker for breast cancer progression.